Formation of isoprostanes in children with type IIa hypercholesterolemia

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 2, 2001, Pages 228-231

  Cracowski, Jean Luc ^a   Ploin, Dominique ^a   Bessard, Janine ^a   Baguet, Jean Philippe ^a   Stanke Labesque, Françoise ^a   Mallion, Jean Michel ^a   Bost, Michel ^a   Bessard, Germain ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Child; Hypercholesterolemia; Isoprostanes; Oxidative stress

Indexed keywords

HIGH DENSITY LIPOPROTEIN; ISOPROSTANE; LOW DENSITY LIPOPROTEIN;

ARACHIDONIC ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; URINALYSIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; ISOPROSTANES; LIPID PEROXIDATION; MALE; STATISTICS, NONPARAMETRIC;

EID: 0034913673     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200108000-00008     Document Type: Article

References (18)

1. Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents
2. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
3. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients
4. 2-isoprostanes as an index of oxidative stress in vivo
5. Are isoprostanes a clinical marker for antioxidant drug investigation ?
6. 2 isoprostanes in hypercholesterolemia
7. 2α is increased in hypercholesterolemia
8. 2-isoprostanes, are present in increased amounts in atherosclerotic lesions
9. 2-isoprostanes in human atherosclerotic lesions
10. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
11. 2+ method
12. 2α type-III in human urine by gas chromatography/electronic impact mode mass spectrometry. Comparison with enzyme immunoassay
13. 2α
14. Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine
15. Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia
16. The oxidation hypothesis of atherosclerosis
17. Non-invasive detection of endothelial dysfunction in children and adults at risk for atherosclerosis
18. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment